NCT05436093View on ClinicalTrials.gov

CLDN18.2 Targeting Nanobody Probe for PET Imaging in Solid Tumors

NARecruitingINTERVENTIONAL

Enrollment

15

Participants

Timeline

Start Date

June 23, 2022

Primary Completion Date

June 30, 2024

Study Completion Date

December 31, 2024

Conditions

Solid Tumor

Interventions

DRUG

18F-FDG

All study participants will undergo one 18F-FDG PET/CT scan.

Trial Locations (1)

100142

RECRUITING

Beijing cancer hospital, Beijing

All Listed Sponsors

lead

Peking University Cancer Hospital & Institute

OTHER